Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

66 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Preclinical studies with IL-13PE38QQR for therapy of malignant glioma.
Joshi BH, Husain SR, Puri RK. Joshi BH, et al. Drug News Perspect. 2000 Dec;13(10):599-605. doi: 10.1358/dnp.2000.13.10.858450. Drug News Perspect. 2000. PMID: 12879131
Gene transfer of interleukin 13 receptor alpha2 chain dramatically enhances the antitumor effect of IL-13 receptor-targeted cytotoxin in human prostate cancer xenografts.
Kawakami K, Husain SR, Bright RK, Puri RK. Kawakami K, et al. Cancer Gene Ther. 2001 Nov;8(11):861-8. doi: 10.1038/sj.cgt.7700373. Cancer Gene Ther. 2001. PMID: 11773976
In vivo overexpression of IL-13 receptor alpha2 chain inhibits tumorigenicity of human breast and pancreatic tumors in immunodeficient mice.
Kawakami K, Kawakami M, Snoy PJ, Husain SR, Puri RK. Kawakami K, et al. J Exp Med. 2001 Dec 17;194(12):1743-54. doi: 10.1084/jem.194.12.1743. J Exp Med. 2001. PMID: 11748276 Free PMC article.
Interleukin-13 receptor as a unique target for anti-glioblastoma therapy.
Husain SR, Joshi BH, Puri RK. Husain SR, et al. Int J Cancer. 2001 Apr 15;92(2):168-75. doi: 10.1002/1097-0215(200102)9999:9999<::aid-ijc1182>;2-n. Int J Cancer. 2001. PMID: 11291041
Human breast carcinoma cells express type II IL-4 receptors and are sensitive to antitumor activity of a chimeric IL-4-Pseudomonas exotoxin fusion protein in vitro and in vivo.
Leland P, Taguchi J, Husain SR, Kreitman RJ, Pastan I, Puri RK. Leland P, et al. Mol Med. 2000 Mar;6(3):165-78. Mol Med. 2000. PMID: 10965493 Free PMC article.
66 results
Jump to page